Abstract
Leucine modulates synthetic and degradative pathways in muscle, possibly providing metabolic benefits for both athletes and diseased populations. Leucine has become popular among athletes for improving performance and body composition, however little is known about the metabolic effects of the commonly consumed leucine-derived metabolite β-hydroxy-β-methyl butyrate (HMB). Our work measured the effects of HMB on metabolic protein expression, mitochondrial content and metabolism, as well as lipid content in skeletal muscle cells. Specifically, cultured C2C12 myotubes were treated with either a control or HMB ranging from 6.25 to 25 μM for 24 h and mRNA and/or protein expression, oxygen consumption, glucose uptake, and lipid content were measured. Contrary to leucine’s stimulatory effect on metabolism, HMB-treated cells exhibited significantly reduced regulators of lipid oxidation including peroxisome proliferator-activated receptor alpha (PPARα) and PPARβ/δ, as well as downstream target carnitine palmitoyl transferase, without alterations in glucose or palmitate oxidation. Furthermore, HMB significantly inhibited activation of the master regulator of energetics, AMP-activated protein kinase. As a result, HMB-treated cells also displayed reduced total mitochondrial content compared with true control or cells equivocally treated with leucine. Additionally, HMB treatment amplified markers of lipid biosynthesis (PPARγ and fatty acid synthase) as well as consistently promoted elevated total lipid content versus control cells. Collectively, our results demonstrate that HMB did not improve mitochondrial metabolism or content, and may promote elevated cellular lipid content possibly through heightened PPARγ expression. These observations suggest that HMB may be most beneficial for populations interested in stimulating anabolic cellular processes.
Similar content being viewed by others
Abbreviations
- 2-NBDG:
-
2-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose
- AKT:
-
Protein kinase B
- AMPK:
-
AMP-activated protein kinase
- BCAT2:
-
Branched-chain aminotransferase 2
- BCKDH:
-
Branched-chain-alpha-keto acid dehydrogenase
- CPT1b:
-
Carnitine palmitoyl transferase
- FAS:
-
Fatty acid synthase
- Foxo1:
-
Forkhead box protein O1
- GLUT4:
-
Glucose transporter 4
- MEF2:
-
Myocyte enhancer factor 2
- mTOR:
-
Mammalian target of rapamycin
- NRF1:
-
Nuclear respiratory factor 1
- PGC-1α:
-
Peroxisome proliferator-activated receptor gamma coactivator 1 alpha
- PPARα:
-
Peroxisome proliferator-activated receptor alpha
- PPARβ/δ:
-
Peroxisome proliferator-activated receptor beta/delta
- PPARγ:
-
Peroxisome proliferator-activated receptor gamma
- SIRT1:
-
NAD+-dependent deacetylase sirtuin 1
- SIRT3:
-
NAD+-dependent deacetylase sirtuin 3
- TFAM:
-
Mitochondrial transcription factor A
References
Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MK (2010) Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids 38:1533–1539
Deldicque L, Canedo CS, Horman S, De Potter I, Bertrand L, Hue L, Francaux M (2008) Antagonistic effects of leucine and glutamine on the mTOR pathway in myogenic C2C12 cells. Amino Acids 35:147–155
Du M, Shen QW, Zhu MJ, Ford SP (2007) Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinase. J Anim Sci 85:919–927
Glynn EL, Fry CS, Drummond MJ, Timmerman KL, Dhanani S, Volpi E, Rasmussen BB (2010) Excess leucine intake enhances muscle anabolic signaling but not net protein anabolism in young men and women. J Nutr 140:1970–1976
Haegens A, Schols AM, van Essen AL, van Loon LJ, Langen RC (2012) Leucine induces myofibrillar protein accretion in cultured skeletal muscle through mTOR dependent and independent control of myosin heavy chain mRNA levels. Mol Nutr Food Res 56:741–752
Gannon NP, Vaughan RA (2015) Leucine-induced anabolic-catabolism: two sides of the same coin. Amino Acids 48:321–336
Bruckbauer A, Zemel MB, Thorpe T, Akula MR, Stuckey AC, Osborne D, Martin EB, Kennel S, Wall JS (2012) Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab 9:1–12
Bruckbauer A, Zemel MB (2014) Synergistic effects of polyphenols and methylxanthines with Leucine on AMPK/Sirtuin-mediated metabolism in muscle cells and adipocytes. PLoS One 9:e89166
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB (2015) Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism. Diabetes Metab Syndr Obes 8:227–239
Liang C, Curry BJ, Brown PL, Zemel MB (2014) Leucine modulates mitochondrial biogenesis and SIRT1-AMPK signaling in C2C12 myotubes. J Nutr Metab 2014:239750
Guo K, Yu YH, Hou J, Zhang Y (2010) Chronic leucine supplementation improves glycemic control in etiologically distinct mouse models of obesity and diabetes mellitus. Nutr Metab 7:1–10
Vaughan RA, Garcia-Smith R, Gannon NP, Bisoffi M, Trujillo KA, Conn CA (2013) Leucine treatment enhances oxidative capacity through complete carbohydrate oxidation and increased mitochondrial density in skeletal muscle cells. Amino Acids 45:901–911
Sun X, Zemel MB (2009) Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes. Nutr Metab 6:1–8
He X, Duan Y, Yao K, Li F, Hou Y, Wu G, Yin Y (2016) Beta-hydroxy-beta-methylbutyrate, mitochondrial biogenesis, and skeletal muscle health. Amino Acids 48:653–664
Kimura K, Cheng XW, Inoue A, Hu L, Koike T, Kuzuya M (2014) Beta-hydroxy-beta-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and foxo1/3a phosphorylations and alleviates tumor necrosis factor alpha/interferon gamma-induced murf-1 expression in C2C12 cells. Nutr Res 34:368–374
Nissen S, Sharp R, Ray M, Rathmacher JA, Rice D, Fuller JC, Connelly AS, Abumrad N (1996) Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol 81:2095–2104
Stancliffe RA (2012) Role of beta-hydroxy-beta-methylbutyrate (HMB) in leucine stimulation of mitochondrial biogenesis and fatty acid oxidation. (Thesis) University of Tennessee, Knoxville
Bruckbauer A, Zemel MB (2013) Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity. Diabetes Metab Syndr Obes 6:93–102
Kwon B, Querfurth HW (2015) Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: reversal by oleate is similar to metformin. Biochimie 118:141–150
Schnuck JK, Sunderland KL, Gannon NP, Kuennen MR, Vaughan RA (2016) Leucine stimulates PPARbeta/delta-dependent mitochondrial biogenesis and oxidative metabolism with enhanced GLUT4 content and glucose uptake in myotubes. Biochimie 128–129:1–7
Vallejo J, Spence M, Cheng AL, Brotto L, Edens NK, Garvey SM, Brotto M (2016) Cellular and physiological effects of dietary supplementation with beta-hydroxy-beta-methylbutyrate (HMB) and beta-alanine in late middle-aged mice. PLoS One 11:e0150066
Kornasio R, Riederer I, Butler-Browne G, Mouly V, Uni Z, Halevy O (2009) Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 1793:755–763
Eley HL, Russell ST, Baxter JH, Mukerji P, Tisdale MJ (2007) Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am J Physiol Endocrinol Metab 293:E923–E931
Slater GJ, Jenkins D (2000) Beta-hydroxy-beta-methylbutyrate (HMB) supplementation and the promotion of muscle growth and strength. Sports Med 30:105–116
Pimentel GD, Rosa JC, Lira FS, Zanchi NE, Ropelle ER, Oyama LM, Oller do Nascimento CM, de Mello MT, Tufik S, Santos RV (2011) Beta-hydroxy-beta-methylbutyrate (HMbeta) supplementation stimulates skeletal muscle hypertrophy in rats via the mTOR pathway. Nutr Metab 8:1–7
Gannon NP, Schnuck JK, Mermier CM, Conn CA, Vaughan RA (2015) Trans-cinnamaldehyde stimulates mitochondrial biogenesis through PGC-1alpha and PPARbeta/delta leading to enhanced GLUT4 expression. Biochimie 119:45–51
Hatazawa Y, Tadaishi M, Nagaike Y, Morita A, Ogawa Y, Ezaki O, Takai-Igarashi T, Kitaura Y, Shimomura Y, Kamei Y, Miura S (2014) PGC-1alpha-mediated branched-chain amino acid metabolism in the skeletal muscle. PLoS One 9:e91006
Shimomura Y, Murakami T, Nakai N, Nagasaki M, Harris RA (2004) Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise. J Nutr 134:1583s–1587s
Wilson JM, Fitschen PJ, Campbell B, Wilson GJ, Zanchi N, Taylor L, Wilborn C, Kalman DS, Stout JR, Hoffman JR, Ziegenfuss TN, Lopez HL, Kreider RB, Smith-Ryan AE, Antonio J (2013) International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 10(1):6. doi:10.1186/1550-2783-10-6
Zanchi NE, Gerlinger-Romero F, Guimaraes-Ferreira L, de Siqueira Filho MA, Felitti V, Lira FS, Seelaender M, Lancha AH (2011) HMB supplementation: clinical and athletic performance-related effects and mechanisms of action. Amino Acids 40:1015–1025
Laplante M, Sabatini DM (2013) Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 126:1713–1719
Acknowledgments
Support for this work was provided by the Department of Exercise Science within the Congdon School of Health Sciences. We would like also to thank the Department of Physical Therapy (Congdon School of Health Sciences) and the School of Arts and Sciences for the use of shared lab space and equipment. JKS performed experiments and was the lead author of the manuscript. MAJ and LMG assisted with experiments and manuscript preparation. NPG assisted with manuscript preparation. RAV conducted and oversaw all experiments, designed experiments, oversaw manuscript writing, performed statistical analyses, and conceived the study. All authors read and approved the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors and contributors declare no conflicts of interest.
About this article
Cite this article
Schnuck, J.K., Johnson, M.A., Gould, L.M. et al. Acute β-Hydroxy-β-Methyl Butyrate Suppresses Regulators of Mitochondrial Biogenesis and Lipid Oxidation While Increasing Lipid Content in Myotubes. Lipids 51, 1127–1136 (2016). https://doi.org/10.1007/s11745-016-4193-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-016-4193-2